Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant Escherichia coli. (journals.asm.org)

Authors: Shropshire WC … Shelburne S Journal: Antimicrobial Agents and Chemotherapy Published: 2026-05-06 DOI: https://doi.org/10.1128/aac.01860-25